NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES
NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES
复制标题
DOI:
10.1097/00005792-199009000-00004
复制
发表时间:
1990-09-01
期刊:
影响因子:
1.6
通讯作者:
VICKERS, RM
中科院分区:
文献类型:
--
作者:
FANG, GD;FINE, M;VICKERS, RM
Pneumonia results in more than 500,000 hospital admissions annually in adults and ranks as the sixth leading cause of death in the United States (1, 2). Despite progress in diagnostic techniques and treatments, management of pneumonia remains challenging, because the precise etiology re-mains uncertain in as many as 49% of cases (Table 1). Moreover, new agents have been implicated as causes of community-acquired pneumonia. Given the broad spectrum of diagnostic possibilities, management has become more complex, as empiric therapy is usually required at the outset and precise etiologic diagnosis requires results of laboratory tests, which may not be immediately available. Our specific goal was to provide current information on the frequency of microbial etiologies for community-acquired pneumonia in the modern-day era such that an updated approach to diagnosis and management could be rationally formulated. Since many of the newly discovered or newly appreciated agents require therapy different from that used for the more traditional pathogens, this information would be pertinent in selection of empiric antibiotic therapy. We, therefore, conducted a 1-year prospective multicenter study of patients admitted for pneumonia to a private community, a university, and a Veterans Administration hospital. Newer specialized laboratory methods as well as estab-lished methods for diagnosis of pneumonia were routinely used for patients entered into the study.